Started: 1/2010
Study Name: An Open-Label, Dose-Escalating Study Of The Pharmacokinetics, Safety And Tolerability Of study drug In Pediatric Overactive Bladder Patients Aged 8-17 Years
Indication: UTI
Principal Investigator: Brad Brabec
Started: 1/2010
Study Name: An Open-Label, Dose-Escalating Study Of The Pharmacokinetics, Safety And Tolerability Of study drug In Pediatric Overactive Bladder Patients Aged 8-17 Years
Indication: UTI
Principal Investigator: Brad Brabec
A Phase 3 study to evaluate the safety, Tolerability, and immunogenicity of a multivalent…
A Phase 3, study to evaluate the safety, tolerability, and immunogenicity of…